Maven Securities’s Amedisys AMED Stock Holding History

Maven Securities’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6,200	Closed	-$610K	–	462
2025 Q2	$610K	Buy	+6,200	New	+$587K	0.01%	557
2024 Q4	–	Sell	-27,200	Closed	-$2.63M	–	810
2024 Q3	$2.63M	Sell	27,200 -4,800	-15%	-$468K	0.05%	297
2024 Q2	$2.94M	Buy	+32,000	New	+$2.97M	0.07%	294
2024 Q1	–	Sell	-5,000	Closed	-$475K	–	365
2023 Q4	$475K	Buy	+5,000	New	+$467K	0.01%	675
2023 Q3	–	Sell	-80,000	Closed	-$7.32M	–	1064
2023 Q2	$7.32M	Buy	+80,000	New	+$6.56M	0.11%	101

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Maven Securities's AMED Position: Q2 2025 in Review

Maven Securities sold out of Amedisys (AMED) in Q2 2025, closing a stake of 5,000 shares — an estimated $473K sold.

Maven Securities first reported a position in AMED in Q2 2024 and held it in 4 quarters. The position peaked at $3.32M in Q4 2024. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

Maven Securities reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
Maven Securities sold 5,000 Amedisys shares in Q2 2025, an estimated $473K.
Maven Securities first reported a position in Amedisys in Q2 2024 and held it in 4 quarters.
Maven Securities's Amedisys position peaked at $3.32M in Q4 2024.
319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on Maven Securities's 13F filing for Q2 2025, filed 14 Aug 2025.